Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Faster, Cleaner, Better.

Amag Pharmaceuticals (AMAG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2010	06-2010	03-2010	12-2009	09-2009
Assets
Current Assets
Cash & Cash Equivalents	104,384	135,793	212,747	50,126	62,302
Marketable Securities	169,563	153,337	21,044	29,578	39,061
Receivables	8,212	15,259	75,004	27,350	16,454
Inventories	16,826	15,431	12,041	9,415	5,532
Other current assets	0	0	788	788	779
TOTAL	$306,678	$324,750	$326,524	$122,729	$128,163

Non-Current Assets
PPE Net	11,736	11,886	12,064	12,417	11,231
Investments And Advances	34,053	38,876	48,432	49,013	49,701
Other Non-Current Assets	460	460	460	460	460
TOTAL	$46,249	$51,222	$60,956	$61,890	$61,392

Total Assets	$352,927	$375,972	$387,480	$184,619	$189,555

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	2,311	3,855	4,146	5,432	1,960
Accrued Expenses	25,586	27,548	20,515	21,931	15,871
TOTAL	$35,981	$43,770	$38,919	$37,561	$29,281

Non-Current Liabilities
Deferred Revenues	8,084	12,367	14,258	10,198	11,450
Other Non-Current Liabilities	2,862	2,936	3,011	3,081	3,141
TOTAL	$55,678	$56,436	$58,011	$4,081	$4,141

Total Liabilities	$91,659	$100,206	$96,930	$41,642	$33,422

Shareholders' Equity
Shares Outstanding, K	21,116	21,050	21,011	20,988	17,133
Common Shares	211	210	210	174	171
Retained earnings	-343,059	-326,063	-304,739	-281,686	-263,274
Other shareholders' equity	-6,774	-7,509	-8,061	-7,925	-6,370
TOTAL	$261,268	$275,766	$290,550	$142,977	$156,133

Total Liabilities And Equity	$352,927	$375,972	$387,480	$184,619	$189,555